“The human syncytiotrophoblast (hST) has a major role in the production of important placental hormones.
Several molecules regulate hST endocrine function but the role of endocannabinoids in this process is still unknown.
Here, we report that the endocannabinoid anandamide (AEA) decreased cAMP levels, impaired human chorionic gonadotropin secretion, placental alkaline phosphatase activity and decreased aromatase mRNA levels and protein expression, through cannabinoid (CB) receptor activation.
AEA also downregulated leptin and placental protein 13 transcription, though via a CB receptor-independent mechanism.
All this evidence suggests AEA is a novel modulator of hormone synthesis by the syncytiotrophoblast, supporting the importance of the endocannabinoid signalling in placental function.”